-
1
-
-
55449120805
-
Genetic mapping in human disease
-
D. Altschuler, M. J. Daly, E. S. Lander, "Genetic Mapping in Human Disease," Science 322 (2008): 881-888.
-
(2008)
Science
, vol.322
, pp. 881-888
-
-
Altschuler, D.1
Daly, M.J.2
Lander, E.S.3
-
2
-
-
77953397764
-
Systems medicine: The future of medical genomics and healthcare
-
C. Auffray, Z. Chen, L. Hood, "Systems Medicine: The Future of Medical Genomics and Healthcare," Genome Medicine I (2009): 2.1-2.13.
-
(2009)
Genome Medicine
, vol.I
, pp. 21-213
-
-
Auffray, C.1
Chen, Z.2
Hood, L.3
-
3
-
-
54549108740
-
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
-
The Cancer Genome Atlas (TCGA) Research Network
-
The Cancer Genome Atlas (TCGA) Research Network, "Comprehensive Genomic Characterization Defines Human Glioblastoma Genes and Core Pathways," Nature 455 (2008): 1061-1068.
-
(2008)
Nature
, vol.455
, pp. 1061-1068
-
-
-
4
-
-
65449125050
-
Relative contribution of CYP2C9 and VKORC1 Genotype and early INR response to the prediction of warfarin sensitivity during initiation of therapy
-
L. Chun, U. I. Schwarz, M. D. Ritchie, D. M. Roden, C. M. Stein, D. Kurnik, "Relative Contribution of CYP2C9 and VKORC1 Genotype and Early INR Response to the Prediction of Warfarin Sensitivity During Initiation of Therapy," Blood 113 (2009): 3925-3930.
-
(2009)
Blood
, vol.113
, pp. 3925-3930
-
-
Chun, L.1
Schwarz, U.I.2
Ritchie, M.D.3
Roden, D.M.4
Stein, C.M.5
Kurnik, D.6
-
6
-
-
67651166638
-
Generating genome-scale candidate gene lists for pharmacogenomics
-
doi:10.1038/clpt.2009.42
-
N. T. Hansen, S. Brunak, R. B. Altman, "Generating Genome-Scale Candidate Gene Lists for Pharmacogenomics," Clinical Pharmacology Therapeutics, online publication April 15, 2009, doi:10.1038/clpt.2009.42: 1-7.
-
(2009)
Clinical Pharmacology Therapeutics, Online Publication April 15
, pp. 1-7
-
-
Hansen, N.T.1
Brunak, S.2
Altman, R.B.3
-
8
-
-
0032806126
-
If i had a gene test, what would i have and who would i tell?
-
A. G. Motulsky, "If I Had a Gene Test, What Would I Have and Who Would I Tell?" Lancet 354 (1999): SI35-SI37.
-
(1999)
Lancet
, vol.354
-
-
Motulsky, A.G.1
-
12
-
-
13444283596
-
Bias as a threat to the validity of cancer molecular-marker research
-
DOI 10.1038/nrc1550
-
D. F. Ransohoff, "Bias As a Threat to the Validity of Cancer Molecular-Marker Research." Nature Reviews Cancer 5 (2005): 142-149. (Pubitemid 40215862)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.2
, pp. 142-149
-
-
Ransohoff, D.F.1
-
13
-
-
57349180697
-
Currents in Contemporary Ethics: GINA, the ADA, and Genetic Discrimination in Employment
-
Winter
-
M. A. Rothstein, "Currents in Contemporary Ethics: GINA, the ADA, and Genetic Discrimination in Employment," Journal of Law, Medicine & Ethics (Winter 2008): 837-840.
-
(2008)
Journal of Law, Medicine & Ethics
, pp. 837-840
-
-
Rothstein, M.A.1
|